Use of EDG receptor binding agents in cancer

摘要

Provided Is a method for treating solid tumors, e.g tumor Invasiveness, and particularly inhibiting or controlling deregulated angiogenesis, using a sphingosine-1 -phosphate receptor agonist, optionally in combination with a chemotherapeutic agent. The invention also comprises a combination of a sphingosine-1-phosphate receptor agonist with a chemotherapeutic agent.